Home > Research > Publications & Outputs > Quantification of phase I/II metabolizing enzym...
View graph of relations

Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate. / John, Kaarthik; Ragavan, Narasimhan; Pratt, M. Margaret et al.
In: The Prostate, Vol. 69, No. 5, 01.04.2009, p. 505-519.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

John, K, Ragavan, N, Pratt, MM, Singh, PB, Al-Buheissi, S, Matanhelia, SS, Phillips, DH, Poirier, MC & Martin, FL 2009, 'Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.', The Prostate, vol. 69, no. 5, pp. 505-519. https://doi.org/10.1002/pros.20898

APA

John, K., Ragavan, N., Pratt, M. M., Singh, P. B., Al-Buheissi, S., Matanhelia, S. S., Phillips, D. H., Poirier, M. C., & Martin, F. L. (2009). Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate. The Prostate, 69(5), 505-519. https://doi.org/10.1002/pros.20898

Vancouver

John K, Ragavan N, Pratt MM, Singh PB, Al-Buheissi S, Matanhelia SS et al. Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate. The Prostate. 2009 Apr 1;69(5):505-519. doi: 10.1002/pros.20898

Author

John, Kaarthik ; Ragavan, Narasimhan ; Pratt, M. Margaret et al. / Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate. In: The Prostate. 2009 ; Vol. 69, No. 5. pp. 505-519.

Bibtex

@article{84098141221f4edabc7c970c2b3a253a,
title = "Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.",
abstract = "BACKGROUND Studies of migrant populations suggest that dietary and/or environmental factors play a crucial role in the etiology of prostatic adenocarcinoma (CaP). The human prostate consists of the peripheral zone (PZ), transition zone (TZ), and central zone (CZ); CaP occurs most often in the PZ. METHODS To investigate the notion that an underlying differential expression of phase I/II genes, and/or the presence of polycyclic aromatic hydrocarbon (PAH)-DNA adducts might explain the elevated PZ susceptibility, we examined prostate tissues (matched tissue sets consisting of PZ and TZ) from men undergoing radical retropubic prostatectomy for CaP (n = 26) or cystoprostatectomy (n = 1). Quantitative gene expression analysis was employed for cytochrome P450 (CYP) isoforms CYP1A1, CYP1B1, and CYP1A2, as well as N-acetyltransferase 1 and 2 (NAT1 and NAT2) and catechol-O-methyl transferase (COMT). RESULTS CYP1B1, NAT1, and COMT were expressed in all tissue sets; levels of CYP1B1 and NAT1 were consistently higher in the PZ compared to TZ. Immunohistochemistry confirmed the presence of CYP1B1 (nuclear-associated and primarily in basal epithelial cells) and NAT1. Normal tissue from 23 of these aforementioned 27 matched tissue sets was analyzed for PAH-DNA adduct levels using antiserum elicited against DNA modified with r,7t8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydro-benzo[a]pyrene (BPDE). PAH-DNA adduct levels were highest in glandular epithelial cells, but a comparison of PZ and TZ showed no significant differences. CONCLUSION Although expression of activating and/or detoxifying enzymes may be higher in the PZ, PAH-DNA adduct levels appear to be similar in both zones. Therefore, factors other than PAH-DNA adducts may be responsible for promotion of tumor formation in the human prostate.",
keywords = "automated cellular imaging system • immunohistochemistry • peripheral zone • radical retropubic prostatectomy • RT-PCR • transition zone",
author = "Kaarthik John and Narasimhan Ragavan and Pratt, {M. Margaret} and Singh, {Paras B.} and Salah Al-Buheissi and Matanhelia, {Shyam S.} and Phillips, {David H.} and Poirier, {Miriam C.} and Martin, {Frank L.}",
year = "2009",
month = apr,
day = "1",
doi = "10.1002/pros.20898",
language = "English",
volume = "69",
pages = "505--519",
journal = "The Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.

AU - John, Kaarthik

AU - Ragavan, Narasimhan

AU - Pratt, M. Margaret

AU - Singh, Paras B.

AU - Al-Buheissi, Salah

AU - Matanhelia, Shyam S.

AU - Phillips, David H.

AU - Poirier, Miriam C.

AU - Martin, Frank L.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - BACKGROUND Studies of migrant populations suggest that dietary and/or environmental factors play a crucial role in the etiology of prostatic adenocarcinoma (CaP). The human prostate consists of the peripheral zone (PZ), transition zone (TZ), and central zone (CZ); CaP occurs most often in the PZ. METHODS To investigate the notion that an underlying differential expression of phase I/II genes, and/or the presence of polycyclic aromatic hydrocarbon (PAH)-DNA adducts might explain the elevated PZ susceptibility, we examined prostate tissues (matched tissue sets consisting of PZ and TZ) from men undergoing radical retropubic prostatectomy for CaP (n = 26) or cystoprostatectomy (n = 1). Quantitative gene expression analysis was employed for cytochrome P450 (CYP) isoforms CYP1A1, CYP1B1, and CYP1A2, as well as N-acetyltransferase 1 and 2 (NAT1 and NAT2) and catechol-O-methyl transferase (COMT). RESULTS CYP1B1, NAT1, and COMT were expressed in all tissue sets; levels of CYP1B1 and NAT1 were consistently higher in the PZ compared to TZ. Immunohistochemistry confirmed the presence of CYP1B1 (nuclear-associated and primarily in basal epithelial cells) and NAT1. Normal tissue from 23 of these aforementioned 27 matched tissue sets was analyzed for PAH-DNA adduct levels using antiserum elicited against DNA modified with r,7t8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydro-benzo[a]pyrene (BPDE). PAH-DNA adduct levels were highest in glandular epithelial cells, but a comparison of PZ and TZ showed no significant differences. CONCLUSION Although expression of activating and/or detoxifying enzymes may be higher in the PZ, PAH-DNA adduct levels appear to be similar in both zones. Therefore, factors other than PAH-DNA adducts may be responsible for promotion of tumor formation in the human prostate.

AB - BACKGROUND Studies of migrant populations suggest that dietary and/or environmental factors play a crucial role in the etiology of prostatic adenocarcinoma (CaP). The human prostate consists of the peripheral zone (PZ), transition zone (TZ), and central zone (CZ); CaP occurs most often in the PZ. METHODS To investigate the notion that an underlying differential expression of phase I/II genes, and/or the presence of polycyclic aromatic hydrocarbon (PAH)-DNA adducts might explain the elevated PZ susceptibility, we examined prostate tissues (matched tissue sets consisting of PZ and TZ) from men undergoing radical retropubic prostatectomy for CaP (n = 26) or cystoprostatectomy (n = 1). Quantitative gene expression analysis was employed for cytochrome P450 (CYP) isoforms CYP1A1, CYP1B1, and CYP1A2, as well as N-acetyltransferase 1 and 2 (NAT1 and NAT2) and catechol-O-methyl transferase (COMT). RESULTS CYP1B1, NAT1, and COMT were expressed in all tissue sets; levels of CYP1B1 and NAT1 were consistently higher in the PZ compared to TZ. Immunohistochemistry confirmed the presence of CYP1B1 (nuclear-associated and primarily in basal epithelial cells) and NAT1. Normal tissue from 23 of these aforementioned 27 matched tissue sets was analyzed for PAH-DNA adduct levels using antiserum elicited against DNA modified with r,7t8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydro-benzo[a]pyrene (BPDE). PAH-DNA adduct levels were highest in glandular epithelial cells, but a comparison of PZ and TZ showed no significant differences. CONCLUSION Although expression of activating and/or detoxifying enzymes may be higher in the PZ, PAH-DNA adduct levels appear to be similar in both zones. Therefore, factors other than PAH-DNA adducts may be responsible for promotion of tumor formation in the human prostate.

KW - automated cellular imaging system • immunohistochemistry • peripheral zone • radical retropubic prostatectomy • RT-PCR • transition zone

U2 - 10.1002/pros.20898

DO - 10.1002/pros.20898

M3 - Journal article

VL - 69

SP - 505

EP - 519

JO - The Prostate

JF - The Prostate

SN - 0270-4137

IS - 5

ER -